Cargando…

Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study

BACKGROUND: There is a limited understanding of the patient and family experience of Chronic Transfusion Therapy (CTT) for prevention of complications of Sickle Cell Disease (SCD). We sought to understand patient and family experience with CTT using qualitative methods. METHODS: Fifteen parents of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawkins, Lauren M., Sinha, Cynthia B., Ross, Diana, Yee, Marianne E. M., Quarmyne, Maa-Ohui, Krishnamurti, Lakshmanan, Bakshi, Nitya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165370/ https://www.ncbi.nlm.nih.gov/pubmed/32305060 http://dx.doi.org/10.1186/s12887-020-02078-w

Ejemplares similares

Decision-making about gene therapy in transfusion dependent thalassemia
por: Quarmyne, Maa-Ohui, et al.
Publicado: (2022)

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study
por: Bakshi, Nitya, et al.
Publicado: (2020)

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
por: Sinha, Cynthia B., et al.
Publicado: (2019)

From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
por: Sinha, Cynthia B., et al.
Publicado: (2018)

Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease
por: Sinha, Cynthia B., et al.
Publicado: (2020)

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2017)

Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
por: Veludhandi, Anirudh, et al.
Publicado: (2021)

Acute Chest Syndrome in Children with Sickle Cell Disease
por: Jain, Shilpa, et al.
Publicado: (2017)

Improving an Administrative Case Definition for Longitudinal Surveillance of Sickle Cell Disease
por: Snyder, Angela B., et al.
Publicado: (2019)

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode
por: Bakshi, Nitya, et al.
Publicado: (2018)

Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study
por: Bakshi, Nitya, et al.
Publicado: (2022)

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2023)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

Assessing Patient Preferences for Treatment Options for Pediatric Sickle Cell Disease: A Critical Review of Quantitative and Qualitative Studies
por: Katoch, Deeksha, et al.
Publicado: (2021)

Comparative Effectiveness of a Web-Based Patient Decision Aid for Therapeutic Options for Sickle Cell Disease: Randomized Controlled Trial
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2019)

Sex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease
por: Astles, Rachel, et al.
Publicado: (2023)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility Study
por: Rodgers-Melnick, Samuel N, et al.
Publicado: (2022)

Prevalence and predictors of chronic pain intensity and disability among adults with sickle cell disease
por: Matthie, Nadine, et al.
Publicado: (2020)

Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
por: Chiang, Kate Chander, et al.
Publicado: (2023)

The role of the arginine metabolome in pain: implications for sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2016)

Transfusion therapy for sickle cell disease: what’s new?
por: Chou, Stella T., et al.
Publicado: (2022)

Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia
por: Meier, Emily R., et al.
Publicado: (2020)

Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia
por: Kaushal, Megha, et al.
Publicado: (2016)

Correction to: T Cell‑Epstein‑Barr Virus–Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non‑Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH
por: Shamriz, Oded, et al.
Publicado: (2021)

T Cell-Epstein-Barr Virus–Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH
por: Shamriz, Oded, et al.
Publicado: (2021)

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2022)

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020)

Association of genetic variation in COMT gene with pain related to sickle cell disease in patients from the walk-PHaSST study
por: Zhang, Yingze, et al.
Publicado: (2018)

O-07: TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

Best practices for transfusion for patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2010)

Red cell transfusion and alloimmunization in sickle cell disease
por: Linder, Grace E., et al.
Publicado: (2021)

Red blood cell transfusion in sickle cell disease
por: Uminski, Kelsey, et al.
Publicado: (2023)

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022)

Blood Transfusion Frequency and Indications in Yemeni Children with Sickle Cell Disease
por: Al-Saqladi, Abdul-Wahab M., et al.
Publicado: (2020)

Parent Perspectives on Family-Centered Pediatric Electronic Consultations: Qualitative Study
por: Verma, Rhea, et al.
Publicado: (2020)

Neurological Complications following Blood Transfusions in Sickle Cell Anemia
por: Alharbi, Hana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_86ghqgds35p7p044e6s0917sgb